NHS England to fund Duodopa

News

Author: Parkinson's Life editorsPublished: 28 August 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The NHS in England has announced they will fund Duodopa – a life-changing drug for people with advanced Parkinson’s – after campaigners managed to garner the support of nearly a hundred MPs who signed a petition.

This means that should a specialist Parkinson’s clinician prescribe Duodopa, a patient will be able to receive it without delay. Duodopa can help to control the symptoms of advanced Parkinson’s when all other treatments have stopped working.

The petition signed by 98 MPs put pressure on NHS England to act urgently to address the situation.

Laura Cockram, policy and campaigns manager at Parkinson’s UK said: “I am elated that the NHS has finally arrived at this decision. We know this treatment has had transformative effects on many that have been treated with it and how vital it is that those who need Duodopa receive it without delay. This is an important day for Parkinson’s care.”

 

Go Back

Share this story

Comments


Related articles


Dr Lennart Stieglitz

sponsored article

Advances

5 things you might not know about DBS

Diving deeper into deep brain stimulation with Dr Lennart Stieglitz

READ MORE
Melissa McConaghy

Interviews

Insight into Parkinson’s: “join us as we make history”

We talk to the founder of the ‘Insight into Parkinson’s’ summit

READ MORE

Global update

Teenager raises over $40,000 for Parkinson’s research

Jenna Sigurdson, 13, raised more than $40,000 for research into Parkinson's

READ MORE